
    
      This is a phase 1, open-label, randomized, single dose, crossover clinical trial to assess
      the effect of food on the pharmacokinetics of YHD1119 in healthy male volunteers.

      Group 1: 12 subjects will be assigned and they will be administered YHD1119 in fasted state
      at Day 1 and in fed state at Day 8.

      Group 2: 12 subjects will be assigned and they will be administered YHD1119 in fed state at
      Day 1 and in fasted state at Day 8.
    
  